NCT03789240 2026-03-03Response-Adapted Therapy With Copanlisib and Rituximab in Untreated Follicular LymphomaNational Institutes of Health Clinical Center (CC)Phase 2 Active not recruiting33 enrolled 17 charts
NCT04750941 2025-03-04Study of Copanlisib and Ketogenic DietColumbia UniversityPhase 2 Terminated1 enrolled 9 charts